β(1C) integrin in epithelial cells correlates with a nonproliferative phenotype: Forced expression of β(1C) inhibits prostate epithelial cell proliferation

Mara Fornaro, Michela Manzotti, Giovanni Tallini, Amy E. Slear, Silvano Bosari, Erkki Ruoslahti, Lucia R. Languino

Research output: Contribution to journalArticle

Abstract

The expression of the β(1C) integrin, an alternatively spliced variant of the β1 subunit, was investigated in human adult and fetal tissues. In the adult, β(1C) immunoreactivity was found in nonproliferative, differentiated simple, and/or pseudostratified epithelia in prostate glands and liver bile ducts. In contrast, β(1C) was undetectable in stratified squamous epithelium of the epidermis and/or in hepatocytes. Luminal prostate epithelial cells expressed β(1C) in vivo and in vitro, but no β(1C) was seen in basal cells, which are proliferating cells. Fetal prostate expressed β(1C) in differentiated glands that had a defined lumen, but not in budding glands, indicating that β(1C) is a marker of prostate epithelium differentiation. The β(1C) and the common β(1A) variants are differentially distributed: β(1A) was found in luminal and basal epithelial as well as in stromal cells in the prostate. In the liver, β(1C) and β(1A) were coexpressed in biliary epithelium, whereas vascular cells expressed only β(1A). Because we found β(1C) in nonproliferative and differentiated epithelium, we investigated whether β(1C) could have a causal role in inhibiting epithelial cell proliferation. The results showed that exogenous expression of a β(1C), but not of a β(1A), cytoplasmic domain chimeric construct, completely inhibited thymidine incorporation in response to serum by prostate cancer epithelial cells. Consistent with these in vitro results, β(1C) appeared to be downregulated in prostate glands that exhibit regenerative features in benign hyperplastic epithelium. These data show that the presence of β(1C) integrins in epithelial cells correlates with a nonproliferative, differentiated phenotype and is growth inhibitory to prostate epithelial cells in vitro. These findings indicate a novel pathophysiological role for this integrin variant in epithelial cell proliferation.

Original languageEnglish
Pages (from-to)1079-1087
Number of pages9
JournalAmerican Journal of Pathology
Volume153
Issue number4
Publication statusPublished - Oct 1998

Fingerprint

Integrins
Prostate
Epithelial Cells
Cell Proliferation
Epithelium
Phenotype
Liver
Stromal Cells
Bile Ducts
Epidermis
Thymidine
Blood Vessels
Hepatocytes
Prostatic Neoplasms
Fetus
Down-Regulation
Growth
Serum
In Vitro Techniques

ASJC Scopus subject areas

  • Pathology and Forensic Medicine

Cite this

β(1C) integrin in epithelial cells correlates with a nonproliferative phenotype : Forced expression of β(1C) inhibits prostate epithelial cell proliferation. / Fornaro, Mara; Manzotti, Michela; Tallini, Giovanni; Slear, Amy E.; Bosari, Silvano; Ruoslahti, Erkki; Languino, Lucia R.

In: American Journal of Pathology, Vol. 153, No. 4, 10.1998, p. 1079-1087.

Research output: Contribution to journalArticle

Fornaro, Mara ; Manzotti, Michela ; Tallini, Giovanni ; Slear, Amy E. ; Bosari, Silvano ; Ruoslahti, Erkki ; Languino, Lucia R. / β(1C) integrin in epithelial cells correlates with a nonproliferative phenotype : Forced expression of β(1C) inhibits prostate epithelial cell proliferation. In: American Journal of Pathology. 1998 ; Vol. 153, No. 4. pp. 1079-1087.
@article{72e355700d1f46748cd57df6d6da9666,
title = "β(1C) integrin in epithelial cells correlates with a nonproliferative phenotype: Forced expression of β(1C) inhibits prostate epithelial cell proliferation",
abstract = "The expression of the β(1C) integrin, an alternatively spliced variant of the β1 subunit, was investigated in human adult and fetal tissues. In the adult, β(1C) immunoreactivity was found in nonproliferative, differentiated simple, and/or pseudostratified epithelia in prostate glands and liver bile ducts. In contrast, β(1C) was undetectable in stratified squamous epithelium of the epidermis and/or in hepatocytes. Luminal prostate epithelial cells expressed β(1C) in vivo and in vitro, but no β(1C) was seen in basal cells, which are proliferating cells. Fetal prostate expressed β(1C) in differentiated glands that had a defined lumen, but not in budding glands, indicating that β(1C) is a marker of prostate epithelium differentiation. The β(1C) and the common β(1A) variants are differentially distributed: β(1A) was found in luminal and basal epithelial as well as in stromal cells in the prostate. In the liver, β(1C) and β(1A) were coexpressed in biliary epithelium, whereas vascular cells expressed only β(1A). Because we found β(1C) in nonproliferative and differentiated epithelium, we investigated whether β(1C) could have a causal role in inhibiting epithelial cell proliferation. The results showed that exogenous expression of a β(1C), but not of a β(1A), cytoplasmic domain chimeric construct, completely inhibited thymidine incorporation in response to serum by prostate cancer epithelial cells. Consistent with these in vitro results, β(1C) appeared to be downregulated in prostate glands that exhibit regenerative features in benign hyperplastic epithelium. These data show that the presence of β(1C) integrins in epithelial cells correlates with a nonproliferative, differentiated phenotype and is growth inhibitory to prostate epithelial cells in vitro. These findings indicate a novel pathophysiological role for this integrin variant in epithelial cell proliferation.",
author = "Mara Fornaro and Michela Manzotti and Giovanni Tallini and Slear, {Amy E.} and Silvano Bosari and Erkki Ruoslahti and Languino, {Lucia R.}",
year = "1998",
month = "10",
language = "English",
volume = "153",
pages = "1079--1087",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "4",

}

TY - JOUR

T1 - β(1C) integrin in epithelial cells correlates with a nonproliferative phenotype

T2 - Forced expression of β(1C) inhibits prostate epithelial cell proliferation

AU - Fornaro, Mara

AU - Manzotti, Michela

AU - Tallini, Giovanni

AU - Slear, Amy E.

AU - Bosari, Silvano

AU - Ruoslahti, Erkki

AU - Languino, Lucia R.

PY - 1998/10

Y1 - 1998/10

N2 - The expression of the β(1C) integrin, an alternatively spliced variant of the β1 subunit, was investigated in human adult and fetal tissues. In the adult, β(1C) immunoreactivity was found in nonproliferative, differentiated simple, and/or pseudostratified epithelia in prostate glands and liver bile ducts. In contrast, β(1C) was undetectable in stratified squamous epithelium of the epidermis and/or in hepatocytes. Luminal prostate epithelial cells expressed β(1C) in vivo and in vitro, but no β(1C) was seen in basal cells, which are proliferating cells. Fetal prostate expressed β(1C) in differentiated glands that had a defined lumen, but not in budding glands, indicating that β(1C) is a marker of prostate epithelium differentiation. The β(1C) and the common β(1A) variants are differentially distributed: β(1A) was found in luminal and basal epithelial as well as in stromal cells in the prostate. In the liver, β(1C) and β(1A) were coexpressed in biliary epithelium, whereas vascular cells expressed only β(1A). Because we found β(1C) in nonproliferative and differentiated epithelium, we investigated whether β(1C) could have a causal role in inhibiting epithelial cell proliferation. The results showed that exogenous expression of a β(1C), but not of a β(1A), cytoplasmic domain chimeric construct, completely inhibited thymidine incorporation in response to serum by prostate cancer epithelial cells. Consistent with these in vitro results, β(1C) appeared to be downregulated in prostate glands that exhibit regenerative features in benign hyperplastic epithelium. These data show that the presence of β(1C) integrins in epithelial cells correlates with a nonproliferative, differentiated phenotype and is growth inhibitory to prostate epithelial cells in vitro. These findings indicate a novel pathophysiological role for this integrin variant in epithelial cell proliferation.

AB - The expression of the β(1C) integrin, an alternatively spliced variant of the β1 subunit, was investigated in human adult and fetal tissues. In the adult, β(1C) immunoreactivity was found in nonproliferative, differentiated simple, and/or pseudostratified epithelia in prostate glands and liver bile ducts. In contrast, β(1C) was undetectable in stratified squamous epithelium of the epidermis and/or in hepatocytes. Luminal prostate epithelial cells expressed β(1C) in vivo and in vitro, but no β(1C) was seen in basal cells, which are proliferating cells. Fetal prostate expressed β(1C) in differentiated glands that had a defined lumen, but not in budding glands, indicating that β(1C) is a marker of prostate epithelium differentiation. The β(1C) and the common β(1A) variants are differentially distributed: β(1A) was found in luminal and basal epithelial as well as in stromal cells in the prostate. In the liver, β(1C) and β(1A) were coexpressed in biliary epithelium, whereas vascular cells expressed only β(1A). Because we found β(1C) in nonproliferative and differentiated epithelium, we investigated whether β(1C) could have a causal role in inhibiting epithelial cell proliferation. The results showed that exogenous expression of a β(1C), but not of a β(1A), cytoplasmic domain chimeric construct, completely inhibited thymidine incorporation in response to serum by prostate cancer epithelial cells. Consistent with these in vitro results, β(1C) appeared to be downregulated in prostate glands that exhibit regenerative features in benign hyperplastic epithelium. These data show that the presence of β(1C) integrins in epithelial cells correlates with a nonproliferative, differentiated phenotype and is growth inhibitory to prostate epithelial cells in vitro. These findings indicate a novel pathophysiological role for this integrin variant in epithelial cell proliferation.

UR - http://www.scopus.com/inward/record.url?scp=0031595341&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031595341&partnerID=8YFLogxK

M3 - Article

C2 - 9777939

AN - SCOPUS:0031595341

VL - 153

SP - 1079

EP - 1087

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 4

ER -